Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vaughan Lennox Clift Insider Profile
4 Followers
Vaughan Lennox Clift, Chief Regulatory Affairs at Ampio Pharmaceuticals, holds 575.00K shares in Ampio Pharmaceuticals (Ticker: AMPE).
Vaughan Lennox Clift has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Vaughan Lennox Clift's holdings
Insider Roles
Chief Regulatory Affairs
Roles that Vaughan Lennox Clift holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Vaughan Lennox Clift
Vaughan Lennox Clift's Trading History
List of latest transactions for each holding click on a transaction to see Vaughan Lennox Clift's performance on stock
You May Also Like
Vaughan Lennox Clift insider profile FAQ
What is the percentage of profitable transactions made by Vaughan Lennox Clift?
The percentage of profitable transactions made by Vaughan Lennox Clift is ―.
What is the average return per transaction made by Vaughan Lennox Clift?
The average return per transaction made by Vaughan Lennox Clift is ―.
What stocks does Vaughan Lennox Clift hold?
Vaughan Lennox Clift holds: AMPE stocks.
What was Vaughan Lennox Clift’s latest transaction?
Vaughan Lennox Clift latest transaction was an Uninformative Buy of ―.
What was Vaughan Lennox Clift's most profitable transaction?
Vaughan Lennox Clift’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Vaughan Lennox Clift's role in Ampio Pharmaceuticals?
Vaughan Lennox Clift's role in Ampio Pharmaceuticals is Chief Regulatory Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.